The drug Abatacept (Orencia) nearly eliminated life-threatening severe acute graft-versus-host disease (GvHD) in patients...
The Brotman Baty Institute for Precision Medicine combines the research strengths and capabilities of UW Medicine, Fred...
By launching a bilateral attack on cancer cells, researchers hope to ultimately increase patients’ long-term remission
It Starts With Yes: The Campaign for Seattle Children’s is the largest in Seattle Children’s 110-year history
Beitel assumes role after serving as executive director in the Public Finance Group at JP Morgan
Chaudry assumes role after serving as chief information officer at Cambridge University Hospitals in the United Kingdom
Phase 1 trial aims to increase long-term remission, it is the first on the West Coast to target CD22-positive leukemia
Next-generation sequencing to expand diagnostic information available and guide personalized treatment plans
Findings show certain genetic mutations and family history are common risk factors in children diagnosed with acute...
Phase 1 pilot study utilizes T-cell antigen presenting cells to prolong the persistence of cancer-fighting chimeric antigen...
Please read our press policy before contacting us.
The best way to reach the public relations team is to email email@example.com. To reach us by phone, call 206-987-4500.
Note: This contact information is for members of the media only. For non-media inquiries, call the hospital switchboard at 206-987-2000.
12.29.17 — KUOW
In this tumultuous year, it’s been possible to wonder whether any progress will be made on racial equity. But at the end of...
12.24.17 — Tacoma News Tribune
The tale of Oliver Harrington has a happy ending. It’s a story about a child born premature with virtually no hope of...
12.22.17 — KOMO 4 News
Seattle Children's just launched a new immunotherapy trial for kids who were out of options. That could include 6-year-old...